Introduction
Neoantimycin (1), first isolated in 1967 from Streptomyces orinoci 1 , is a ring-extended member of the antimycin class with a 15-membered tetralactone moiety ( Figure 1 ). The recent discovery of prunustatin A (2) as a selective GRP78 molecular chaperone downregulator highlights the potential of the neoantimycin subfamily as research probes 2, 3, 4 . This discovery may lead to the development of new approaches for fighting cancer since GRP78 is a molecular chaperone critical to the unfolded protein response. Moreover, it has emerged as a new therapeutic target for drugresistant cancer cells and cancer stem cells 5 . absolute stereostructure of 4 has also not yet been determined. The NMR data, including the H12 chemical shifts and coupling constants, of 4 were identical to those of 3. The negative values of specific rotation were reported for 3 and 4 (−28.6° (c 0.01, MeOH) and −10.8° (c 0.1, CHCl3), respectively), indicating that 4 would have the same 15-membered ring as that of 3.
As an extension of our synthetic studies on neoantimycin-class antibiotics 10 , we have been engaged in studies directed toward the total synthesis and stereochemical assignment of 3 and 4. Herein, we report our success in these endeavors.
Results and discussion
We adopted a synthetic strategy for 3 and 4, involving cyclization via transesterification of β-keto ester 7 followed by the late-stage introduction of gem-dimethyl groups at C11 (Scheme 1). Metal saltmediated transesterification of β-keto ester would proceed under mild conditions, which minimizes the epimerization at other stereogenic centers Scheme 1 Retrosynthetic analysis of JBIR-04 (3) and unantimycin A (4).
Our total synthesis of 3 and 4 commenced with the reaction of aldehyde 10, derived from L-phenylalanine, with ethyl diazoacetate in the presence of SnCl2 (0.13 equiv.) 11 , which provided the corresponding β-keto ester 11 in 71% yield as a ca. 2.6 : 1 mixture of tautomers. Removal of the benzyl ether protecting group using Pd(OH)2 in EtOH resulted in the formation of 6 in 69% yield (Scheme 2).
The ring-closure precursor 7 was obtained by condensation of 5 10a and 6 in the presence of DCC and DMAP and subsequent removal of the TBS group with HF in CH3CN (Scheme 3). A mixture of 7 and anhydrous CuSO4 (20 equiv.) in toluene was heated under reflux. The desired transesterification proceeded smoothly to provide the 15-membered tetralactone 8 in 73% yield. The introduction of gem-dimethyl groups at C11 was achieved by treatment of 8 with iodomethane (2.9 equiv.) and Na2CO3 (9.2 equiv.) in DMSO at 40°C for 4 h (Scheme 4). The desired product 13 was obtained in 54% yield. To complete the synthesis of 3, the Cbz group of 13 was removed by hydrogenolysis with Pd(OH)2 in EtOAc to afford 9. The subsequent condensation of 9 with benzoic acid was achieved using EDCI, HOBt, and NMM in DMF to provide synthetic JBIR-04 (3) in 57% yield. The spectral data of synthetic 3 were identical to those reported for a natural sample 6 
Scheme 4 Endgame towards JBIR-04 (3).
We then focused on unantimycin A (4). Condensation of 9 and 3-hydroxybenzoic acid was achieved using EDCI, HOBt, and NMM in DMF to provide synthetic unantimycin A (4) in 55% yield (Scheme 5). The spectral data of synthetic 4 were identical to those reported for a natural sample 9 
Scheme 5 Endgame towards unantimycin A (4).

Conclusions
In summary, the first total syntheses of JBIR-04 and unantimycin A have been achieved. Comparison of our spectroscopic data with those reported for natural samples verified the structure of the natural products; (2S, 4S, 6S, 7R, 9S, 28S) configuration was thus assigned via total synthesis. Further studies on their biological activities are now in progress, and the results will be reported in due course.
Experimental General information and materials
1 H and 13 C NMR spectra were recorded on either Bruker Avance 300 (300 and 75 MHz), Bruker Avance 400 (400 and 100 MHz), JEOL ECZ-400S (400 and 100 MHz), or Bruker Avance III 600 (600 and 150 MHz) instruments. Chemical shifts were reported in parts per million (ppm, δ) relative to Me4Si (0 ppm) and CDCl3 (7.26 ppm for 1 H NMR and 77.0 ppm for 13 C NMR) as the internal reference. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and br = broad), coupling constant in Hz, integration. Coupling constants were determined directly from 1 H and 13 C NMR spectra. Mass spectra were obtained on a JEOL JMS-T100LP (DART, ESI) spectrometer. Infrared (IR) spectra were recorded on a JASCO FT/IR-4600 spectrometer. Optical rotations were measured on a JASCO P-2200 with a path length of 0.1 dm at ambient temperature; the concentrations are reported in g/dL.
Most of the reagents and solvents were purchased from Wako Pure Chemical Industries, Ltd., Tokyo Kasei Kogyo Co., and SigmaAldrich Co. and were used without further purification unless otherwise noted. All air-and moisture-sensitive reactions were carried out in flame-dried, argon-flushed, two-necked flasks sealed with rubber septa, and dry solvents and reagents were introduced using a syringe. THF was freshly distilled from sodium benzophenone ketyl. Flash column chromatography was carried out on Kanto Chemical silica gel 60 N (spherical, neutral, 40-50 μm). Analytical and preparative thin-layer chromatography was performed on Merck precoated silica gel (#5715 Kieselgel 60F254 0.25 mm and #5744 Kieselgel 60F254 0.5 mm, respectively).
Ethyl (S)-4-(benzyloxy)-3-oxo-5-phenylpentanoate (11).
A solution of aldehyde 10 (1.97 g, 8.24 mmol) in CH2Cl2 (14 mL) was added to ethyl diazoacetate (2.68 g, 23.5 mmol) in CH2Cl2 (14 mL) and anhydrous SnCl2 (209 mg, 1.10 mmol) sequentially at 0°C. After being stirred overnight at 0°C, the reaction mixture was washed with aq. sat. NaHCO3 before being dried over Na2SO4 and concentrated. The residue was purified by flash column chromatography (10% EtOAc in n-hexane) to give β-keto ester 11 (ca. 2.6 : 1 mixture of tautomers) as a pale yellow oil ( 1638, 1560, 1542, 1509, 1491, 1457, 1315, 1225, 1095, 1030, 735 4-hydroxy-3-oxo-5-phenylpentanoate (6) . To a solution of 11 (509 mg, 1.56 mmol) in ethanol (20 mL), Pd(OH)2 (224 mg) was added. The resulting suspension was stirred overnight under H2. Then, the mixture was filtered through a pad of Celite®. The filtrate was concentrated in vacuo. Purification by flash column chromatography (20 % EtOAc in n-hexane) afforded 6 as a yellow oil (254 mg, 1.08 mmol, 69%): [α] S)-2'-((N-((benzyloxy)carbonyl)-O-((2'S,3'S)-2'-hydroxy-3'-methylpentanoyl)-L-threonyl)oxy) propanoyl)oxy)-3-oxo-5-phenylpentanoate (7). To a solution of 12 (377 mg, 0.49 mmol) in acetonitrile (8.8 mL) at 0°C, 46.0-48.0% HF aq. (1.3 mL) was added. The reaction mixture was stirred at r.t. for 4 h, before being quenched with sat. NaHCO3 and extracted with EtOAc. The combined organic layers were washed with brine, dried over Na2SO4, and concentrated in vacuo. The product was used in the next step without further purification (315 mg, 0.48 mmol, 98%): [α] 3S,6R,7S,10S,15S)-15-benzyl-10-((S)-sec-butyl)-3,7-dimethyl-2,5,9,12,14-pentaoxo-1,4,8,11 tetraoxacyclopentadecan-6-yl)carbamate (8) . A 300 mL flask containing a mixture of anhydrous CuSO4 (748 mg, 4.69 mmol) and 7 (154 mg, 246 μmol) in toluene (200 mL) was equipped with a small dropping funnel filled with molecular sieves 4A (7.0 g) and a reflux condenser. The mixture was refluxed at 130°C for 5 h. After cooling to r.t., it was filtered to remove CuSO4. The filtrate was concentrated and purified by flash column chromatography (20% EtOAc in n-hexane) to give 8 as a colorless oil (105 mg, 172 μmol, 73%). 13 3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11 tetraoxacyclopentadecan-6-yl)carbamate (13) . To a solution of Na2CO3 (92 mg, 1.35 mmol) in DMSO (1.4 mL) at r.t., a solution of β-keto ester 8 (56 mg, 91.6 μmol) in DMSO (1.3 mL) was added. Then, MeI (18 μL, 289 μmol) was added. The reaction mixture was stirred at r.t. for 4 h, diluted with H2O, and extracted with nhexane/EtOAc (1 : 1, 3x) . The combined organic layers were washed with brine, dried over Na2SO4, and concentrated in vacuo. Purification by flash column chromatography (20% EtOAc in nhexane) afforded 13 as a colorless oil (31 mg, 54 μmol, 54%). 
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